TrialX
Image

Ameliorating the Obstacle of Pap Smear

Ameliorating the Obstacle of Pap Smear

Recruiting
30-70 years
Female
Phase N/A

Overview

To reduce the procedural pain of Pap smear, this study expects to apply the peak-end rule to Pap smear by prolonging the insertion of speculum after samples are obtained from the cervix. This study aims to conduct a randomized controlled study at National Taiwan University Hospital (NTUH). The investigators expect to compare the recalled pain intensity of the intervention and control groups.

Description

Purpose: In order to reduce the procedural pain, this study expects to apply the peak-end rule to Pap smear by prolonging the insertion of speculum after samples are obtained from the cervix. Methods: This study aims to conduct a randomized controlled study at National Taiwan University Hospital (NTUH). Approximately 200 subjects will be recruited. The investigators will utilize the peak-end rule by adding a non-painful event after the most uncomfortable phase in the intervention group. All study subjects are requested to score on a numeric pain scale every 20 seconds during and right after the procedure.

Eligibility

Inclusion Criteria:

  • Biological female
  • Aged 30-70
  • Provision of written informed consent

Exclusion Criteria:

  • History of pelvic or vaginal surgery, active infectious gynecologic complaint, prior intervention for abnormal cervical cytology
  • Incapable of understanding the numeric pain scale
  • Incapable of communicating in Chinese, English or Taiwanese
  • Prior cervical cancer diagnosis
  • Prior hysterectomy
  • Pregnant women
  • Those who use painkillers within 24 hours of this project

Study details
    Pain
    Pain
    Acute Pain Service

NCT04420208

National Taiwan University Hospital

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.